The influence of muscarinic acetylcholine receptors (M1, M4 and M5) and serotonergic 5-HT1A receptor modulation on cognitive deficits in animal model of schizophrenia.
2018/31/N/NZ7/03646
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
- NZ7_16: Inne zagadnienia pokrewne
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Instytut Farmakologii PAN
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 16 – announced on 2018-09-14
- Amount awarded
- 210 000 PLN
- Project start date
- 2019-08-07
- Project end date
- 2022-08-06
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Serotonergic-Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms
- Authors:
- Cieślik Paulina, Radulska Adrianna, Burnat Grzegorz, Kalinowski Leszek, Wierońska Joanna M
- Academic press:
- International journal of molecular sciences (year: 2021, volume: 22, pages: 8612), Publisher: Multidisciplinary Digital Publishing Institute
- Status:
- Published
- DOI:
- 10.3390/ijms22168612 – link to the publication